Immunoperoxidase localization of prostate-specific antigen
- 1 September 1982
- journal article
- research article
- Published by Wolters Kluwer Health in The American Journal of Surgical Pathology
- Vol. 6 (6), 553-558
- https://doi.org/10.1097/00000478-198209000-00007
Abstract
In instances of metastatic tumor from an unknown primary site, it is important to isolate those cases which are attributable to prostatic carcinoma. Immunoperoxidase localization of human prostate-specific antigen (PSA) would be useful in this regard if it were reliably detectable in prostatic carcinoma. We have studied 15 specimens from 14 patients with carcinoma of the prostate by immunoperoxidase techniques. The presence of PSA correlates with the Gleason grade. All cases of Gleason grade 9 or less demonstrated strong staining for PSA. Of the seven specimens with a Gleason grade 10, only four (57%) demonstrated significant staining, while two were entirely devoid of PSA. PSA is thus useful when it is present, but the absence of PSA in a poorly differentiated tumor of undetermined origin does not unequivocally rule out the possibility of a prostatic carcinoma.This publication has 7 references indexed in Scilit:
- PURIFICATION OF A HUMAN PROSTATE SPECIFIC ANTIGEN1Journal of Urology, 2002
- Prostatic-specific antigen: An immunohistologic marker for prostatic neoplasmsCancer, 1981
- Prostate Antigen: A Marker for Human Prostate Epithelial Cells2JNCI Journal of the National Cancer Institute, 1981
- Immunohistochemical diagnosis of prostatic cancer with metastasisCancer, 1980
- Prostatic Origin of Tumors: An Immunohistochemical StudyAmerican Journal of Clinical Pathology, 1980
- A PROSTATE ANTIGEN IN SERA OF PROSTATIC-CANCER PATIENTS1980
- Demonstration of the prostatic origin of metastases.An immunohistochemical method for formalin-fixed embedded tissueCancer, 1978